Tulane University
Also known as: Donald Krogstad | Institute for Clinical Effectiveness and Health Policy | Jing Chen | Jodi Layton, MD | Nakhle Saba, MD | Tulane | Tulane Department of Dermatology | Tulane Medical Center | Tulane School of Medicine | Tulane School of Public Health and Tropical Medicine | Tulane Univeristy | Tulane University | Tulane University Health Sciences Center | Tulane University Medical Center | Tulane University Medical Center, New Orleans, LA | Tulane University Medical School | Tulane University School of Medicine | Tulane University School of Medicine, Department of Dermatology | Tulane University School of Public Health and Tropical Medicine | Tulane University SOM, New Orleans, LA 70112
Highest phase reached
Phase 4
First clinical trial
Dec 1, 1992Last known activity
Sep 30, 2025
Timeline
1830s
- Jan 1, 1834
Tulane University— Founded
Drugs by trial phase (114 distinct, 80 trials)
Phase 4 (23 own, 0 via acquisition)
Phase 3 (34 own, 0 via acquisition)
Phase 2 (33 own, 0 via acquisition)
Phase 1 (13 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Brain Neoplasms
- Breast Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Transitional Cell
- Chagas Disease
- Communicable Diseases
- Congenital Disorders of Glycosylation
- Cutis Laxa
- Cytomegalovirus Retinitis
- Dermatomyositis
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Disease
- Empyema
- Fibrosis
- Glaucoma
- Glaucoma, Open-Angle
- Hemophilia A
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Herpes Zoster
- HIV Infections
- Hypertension
- Hypertension, Pulmonary
- Idiopathic Pulmonary Fibrosis
- Immunologic Deficiency Syndromes
- Infections
- Inflammation
- Insulin Resistance
- Keratosis
- Keratosis, Actinic
- Kidney Diseases
- Kidney Neoplasms
- Leukemia
- Leukemia, Lymphoid
- Lung Diseases
- Lung Neoplasms
- Malaria
- Malaria, Falciparum
- Neoplasm Metastasis
- Neoplasms
- Overweight
- Pleural Diseases
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Prostatic Neoplasms
- Pulmonary Fibrosis
- Purpura
- Purpura, Thrombocytopenic
- Purpura, Thrombocytopenic, Idiopathic
- Purpura, Thrombotic Thrombocytopenic
- Renal Insufficiency, Chronic
- Retinitis
- Staphylococcal Infections
- Stress Disorders, Post-Traumatic
- Stress Disorders, Traumatic
- Trichomonas Infections
- Trichomonas Vaginitis
- Ureteral Neoplasms
- Urinary Bladder Neoplasms
- Vaginitis
Recent trials (50)
- NCT04358211Lead sponsorN/A—
- NCT04358211Sponsor investigatorN/A—
- NCT04854369Lead sponsorN/A—
- NCT04854369Overall official - principal investigatorN/A—
- NCT07077902Lead sponsorPhase 2Sep 30, 2025
- NCT07077902OfficialPhase 2Sep 30, 2025
- NCT06261840Lead sponsorPhase 4Jul 1, 2024
- NCT06261840Sponsor investigatorPhase 4Jul 1, 2024
- NCT06261840OfficialPhase 4Jul 1, 2024
- NCT05992480Overall official - principal investigatorPhase 4Jan 15, 2024
- NCT05992480OfficialPhase 4Jan 15, 2024
- NCT05992480Lead sponsorPhase 4Jan 15, 2024
- NCT05758142Sponsor investigatorN/AMar 29, 2023
- NCT05758142Reponsible party - principal investigatorN/AMar 29, 2023
- NCT05758142Lead sponsorN/AMar 29, 2023
Details
- Founded
- New Orleans, LA, US Jan 1, 1834
- Last known activity
- Sep 30, 2025